Faslodex 250 Mg Injection 5 ml In 1vial About
Faslodex 250 Mg Injection 5 ml In 1vial distinguishes itself as an elite antineoplastic therapy, crafted for superior performance in hormone receptor-positive metastatic breast cancer. Exclusively prescribed for postmenopausal women, this exceptional treatment utilizes a ready-to-use prefilled syringe for convenient intramuscular administration. Manufactured in India for global export, including Canada, EU, UK, USA, and Australia, Faslodex represents the pinnacle of reliability. Explore enhanced patient comfort and consistent results, with each single-dose vial guaranteeing purity and safety. Promotion of effective cancer management has never been more accessible or refined.
Specific Usage and Material Feature: Faslodex 250 Mg Injection Highlights
Faslodex 250 Mg Injection is specifically indicated for treating hormone receptor-positive metastatic breast cancer in postmenopausal women. Its advanced formulation, including 250 mg of Fulvestrant in a prefilled, single-dose syringe, makes it ideal for hospital and specialty clinic settings. The clear, viscous liquid ensures accurate dosing, while its odorless character enhances patient comfort. This elite product is ready to use, reducing preparation time and the risk of contamination, ensuring reliable and consistent therapy every time.
Main Domestic Market and Efficient Order Handling
Faslodex 250 Mg Injection is available for seamless order processing across domestic and international markets, including Canada, EU, UK, USA, and Australia. A transparent sample policy and flexible payment terms ensure user convenience. From the moment your order is processed to safe transportation and timely handover, every step is handled with professionalism. Orders are expeditiously managed to preserve product integrity, thanks to strict cold-chain requirements and well-coordinated logistics that uphold the elite standards of this superior medication.
FAQ's of Faslodex 250 Mg Injection 5 ml In 1vial:
Q: How is Faslodex 250 Mg Injection administered?
A: Faslodex 250 Mg Injection is given as an intramuscular injection, typically once a month, by a healthcare professional as directed by your physician.
Q: What are the main benefits of using Faslodex 250 Mg Injection?
A: The main benefit is its effectiveness in treating hormone receptor-positive metastatic breast cancer in postmenopausal women, offering consistent, easy-to-administer therapy in a prefilled syringe.
Q: When should Faslodex 250 Mg Injection not be used?
A: Faslodex should not be used during pregnancy or in patients who have hypersensitivity to fulvestrant as it may cause adverse reactions.
Q: Where should Faslodex 250 Mg Injection be stored?
A: Store the injection in a refrigerated environment at 2C to 8C. Do not freeze and keep it away from sunlight and out of reach of children.
Q: What is the process for ordering and receiving Faslodex 250 Mg Injection?
A: Orders are processed promptly with coordinated logistics for safe transportation, ensuring the medicine is handed over safely while maintaining strict temperature controls throughout the supply chain.
Q: How does the prefilled syringe feature enhance Faslodex usage?
A: The ready-to-use prefilled syringe minimizes preparation time, reduces risk of dosage errors, and ensures sterile, single-dose administration every time, enhancing reliability and safety.